FrancophonIA/ELRC3.0 huggingface dataset:
English: Since there is a potential for an increase in dose-related adverse events, a decrease in the dose of pioglitazone may be needed when gemfibrozil is concomitantly administered.
Croatian: Budući da postoji mogućnost povećanja nuspojava povezanih s dozom, možda bude potrebno sniziti dozu pioglitazona kod istodobne primjene gemfibrozila.
English: Broken bones have been reported commonly (may affect up to 1 in 10 people) in female patients taking Actos and have also been reported in male patients (frequency cannot be estimated from the available data) taking Actos.
Croatian: Prijelomi kostiju su često prijavljivani (mogu se pojaviti u do 1 na 10 osoba) u žena koje su uzimale Actos, a također su prijavljivani i u muškaraca (učestalost se ne može procijeniti iz dostupnih podataka) koji su uzimali Actos.
English: Your doctor will take this into account when treating your diabetes.
Croatian: Liječnik koji Vas liječi zbog šećerne bolesti to će uzeti u obzir.
English: Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance (see section 4.4).
Croatian: Pioglitazon je također indiciran u kombinaciji s inzulinom u odraslih bolesnika sa šećernom bolešću tipa 2 i nedostatnom kontrolom glikemije pomoću inzulina u kojih je metformin neprikladan zbog kontraindikacija ili nepodnošljivosti (vidjeti dio 4.4).
English: common (may affect up to 1 in 10 people) - headache - dizziness - joint pain - impotence - back pain - shortness of breath - small reduction in red blood cell count - flatulence uncommon (may affect up to 1 in 100 people) - sugar in urine, proteins in urine - increase in enzymes - spinning sensation (vertigo) - sweating - tiredness - increased appetite
Croatian: često (mogu se pojaviti u do 1 na 10 osoba) - glavobolja - omaglica - bol u zglobovima - impotencija - križobolja - nedostatak zraka - malo sniženje broja crvenih krvnih stanica - nadutost manje često (mogu se pojaviti u do 1 na 100 osoba) - šećer u mokraći, proteini u mokraći - povišenje enzima - osjećaj vrtnje (vrtoglavica) - znojenje - umor - pojačan apetit
English: Hepatic impairment Pioglitazone should not be used in patients with hepatic impairment (see sections 4.3 and 4.4).
Croatian: Pioglitazon se ne smije primjenjivati u bolesnika s oštećenjem jetre (vidjeti dio 4.3 i 4.4).
English: Actos contains lactose monohydrate
Croatian: Actos sadrži laktozu hidrat
English: Kaplan-Meier analysis showed shorter time to treatment failure in patients treated with gliclazide, compared with pioglitazone.
Croatian: Kaplan-Meierovom analizom pokazalo se da je vrijeme do prestanka odgovora na terapiju u bolesnika liječenih gliklazidom kraće nego kod liječenja pioglitazonom.
English: - in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin - a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea.
Croatian: kao monoterapija - u odraslih bolesnika (osobito bolesnika s prekomjernom tjelesnom težinom) u kojih se kontrola ne postiže dijetom i tjelovježbom i u kojih metformin nije prikladan zbog kontraindikacija ili nepodnošenja kao dvojna peroralna terapija u kombinaciji s - metforminom, u odraslih bolesnika (osobito bolesnika s prekomjernom tjelesnom težinom) s nedostatnom kontrolom glikemije usprkos monoterapiji metforminom u najvećoj podnošljivoj dozi - sulfonilurejom, samo u odraslih bolesnika s nepodnošenjem metformina ili u kojih je metformin kontraindiciran, s nedostatnom kontrolom glikemije usprkos monoterapiji sulfonilurejom u najvećoj podnošljivoj dozi.
English: In an outcome study of patients with pre-existing major macrovascular disease, the incidence of serious heart failure was 1.6% higher with pioglitazone than with placebo, when added to therapy that included insulin.
Croatian: U ispitivanju ishoda u bolesnika s postojećom teškom makrovaskularnom bolešću, incidencija ozbiljnog zatajenja srca bila je 1,6% viša uz pioglitazon nego uz placebo kad se pioglitazon dodao terapiji koja je uključivala inzulin.
English: as triple oral therapy in combination with - metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.
Croatian: kao trojna peroralna terapija u kombinaciji s - metforminom i sulfonilurejom, u odraslih bolesnika (osobito bolesnika s prekomjernom tjelesnom težinom) s nedostatnom kontrolom glikemije usprkos dvojnoj peroralnoj terapiji.
English: Your doctor will ask you to have blood tests periodically during treatment with Actos.
Croatian: Liječnik će tražiti da za vrijeme liječenja lijekom Actos povremeno napravite krvne pretrage, da bi se provjerilo radi li Vaša jetra normalno.
English: de la Industria 30, 28108 Alcobendas (Madrid), Spain
Croatian: Lilly S.A, Avda. de la Industria 30, 28108 Alcobendas (Madrid), Španjolska
English: If ALT levels are increased to 3 x upper limit of normal during pioglitazone therapy, liver enzyme levels should be reassessed as soon as possible.
Croatian: Ako se tijekom terapije pioglitazonom razine ALT povise na vrijednosti koje su 3 puta iznad gornje granice normale, razine jetrenih enzima treba čim prije ponovno provjeriti.
English: Oy Eli Lilly Finland Ab Puh/Tel: +358 (0)9 8545250
Croatian: Suomi/Finland Oy Eli Lilly Finland Ab Puh/Tel: + 358 (0)9 8545250
English: - hypersensitivity to the active substance or to any of the excipients listed in section 6.1 - cardiac failure or history of cardiac failure (NYHA stages I to IV) - hepatic impairment - diabetic ketoacidosis - current bladder cancer or a history of bladder cancer - uninvestigated macroscopic haematuria
Croatian: - preosjetljivošću na djelatnu tvar ili neku od pomoćnih tvari navedenih u dijelu 6.1 - zatajenjem srca ili anamnezom zatajenja srca (NYHA stadiji I do IV) - oštećenjem funkcije jetre - dijabetičkom ketoacidozom - postojećim ili preboljenim karcinomom mokraćnog mjehura - neispitanom makroskopskom hematurijom.
English: Takeda Belgium Tél/Tel: +32 2 464 06 11 takeda-belgium@takeda.com
Croatian: België/Belgique/Belgien Takeda Belgium Tél/Tel: +32 2 464 06 11 takeda-belgium@takeda.com
English: Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with Actos and insulin experienced the development of heart failure.
Croatian: U nekih bolesnika koji su dugo imali šećernu bolest tipa 2 i srčanu bolest ili su preboljeli moždani udar a liječili su se lijekom Actos i inzulinom došlo je do zatajenja srca.
English: Adverse reactions reported in excess (> 0.5%) of placebo and as more than an isolated case in patients receiving pioglitazone in double-blind studies are listed below as MedDRA preferred term by system organ class and absolute frequency.
Croatian: Nuspojave koje su bile zabilježene češće (> 0,5%) nego uz placebo ili kao izolirani slučaj u bolesnika koji su primali pioglitazon u dvostruko slijepim ispitivanjima navedene su niže prema MedDRA pojmovima, klasifikaciji organskih sustava i apsolutnoj učestalosti.
English: In most clinical trials, reduced total plasma triglycerides and free fatty acids, and increased HDL-cholesterol levels were observed as compared to placebo, with small, but not clinically significant increases in LDL-cholesterol levels.
Croatian: U većini kliničkih ispitivanja primijećeno je sniženje ukupnih triglicerida i slobodnih masnih kiselina u plazmi te povišenje razine HDL-kolesterola u usporedbi s placebom, uz mala ali ne i klinički značajna povišenja razine LDL-kolesterola.
English: There may be an increased possibility of becoming pregnant because you may ovulate again when you take Actos.
Croatian: Kad uzimate Actos, možete ponovno imati ovulaciju pa mogućnost trudnoće može biti povećana.
English: Musculoskeletal and connective tissue disorders fracture bone4
Croatian: Poremećaji mišićnokoštanog sustava i vezivnog tkiva prijelom kosti4
English: Takeda UK Ltd Tel: +44 (0)1628 537 900
Croatian: United Kingdom Takeda UK Ltd Tel: + 44 (0)1628 537 900
English: Localised swelling (oedema) has also been experienced very commonly (may affect more than 1 in 10 people) in patients taking Actos in combination with insulin.
Croatian: Lokalizirano oteknuće (edemi) također su vrlo često (mogu se pojaviti kod više od 1 na 10 osoba) nastajali u bolesnika koji su uzimali Actos u kombinaciji s inzulinom.
English: In the 3.5 year PROactive study, 44/870 (5.1%) of pioglitazone-treated female patients experienced fractures compared to 23/905 (2.5%) of female patients treated with comparator.
Croatian: U PROactive ispitivanju u trajanju od 3,5 godine, 44/870 (5,1%) bolesnica liječenih pioglitazonom doživjelo je prijelom u usporedbi s 23/905 (2,5%) bolesnica liječenih usporednim lijekom.
English: The effect of pioglitazone (45 mg monotherapy vs. placebo) was studied in a small 18-week trial in type 2 diabetics.
Croatian: Učinak pioglitazona (monoterapija dozom od 45 mg naspram placebo) ispitivao se u malom ispitivanju u trajanju od 18 tjedana u bolesnika sa šećernom bolešću tipa
English: Investigations weight increased6
Croatian: Pretrage povećana tjelesna težina6
English: 3 In controlled clinical trials the incidence of reports of heart failure with pioglitazone treatment was the same as in placebo, metformin and sulphonylurea treatment groups, but was increased when used in combination therapy with insulin.
Croatian: U kontroliranim kliničkim ispitivanjima, incidencija prijavljenih zatajenja srca uz liječenje pioglitazonom bila je podjednaka onoj u skupinama koje su primale placebo, metformin ili sulfonilureju, ali povišena kad se pioglitazon primjenjivao u kombiniranoj terapiji s inzulinom.
English: In a placebo controlled trial, patients with inadequate glycaemic control despite a three month insulin optimisation period were randomised to pioglitazone or placebo for 12 months.
Croatian: U placebom kontroliranom ispitivanju, bolesnici s neodgovarajućom kontrolom glikemije usprkos tromjesečnog razdoblja optimizacije inzulina bili su randomizacijom raspodijeljeni u skupinu koja je primala pioglitazon odnosno skupinu koja je primala placebo tijekom 12 mjeseci.
English: Blurred vision due to swelling (or fluid) at the back of the eye has also been reported in patients taking Actos (frequency cannot be estimated from the available data).
Croatian: U bolesnika koji uzimaju Actos zabilježen je i zamagljen vid zbog oticanja (ili nakupljanja tekućine) na stražnjoj strani oka (učestalost se ne može procijeniti iz dostupnih podataka).
English: In PROactive, a cardiovascular outcome study, 5,238 patients with type 2 diabetes mellitus and pre-existing major macrovascular disease were randomised to pioglitazone or placebo in addition to existing antidiabetic and cardiovascular therapy, for up to 3.5 years.
Croatian: U PROactive ispitivanju kardiovaskularnih ishoda, 5238 bolesnika sa šećernom bolešću tipa 2 i postojećom teškom makrovaskularnom bolešću bilo je randomizacijom raspodijeljeno u skupinu koja je primala pioglitazon i onu koja je primala placebo uz postojeću antidijabetičku i kardiovaskularnu terapiju u trajanju do 3,5 godine.
English: Each tablet contains 114.51 mg of lactose monohydrate (see section 4.4).
Croatian: Jedna tableta sadrži 114,51 mg laktoza hidrata (vidjeti dio 4.4).
English: − The active substance in Actos is pioglitazone.
Croatian: Djelatna tvar Actosa je pioglitazon.
English: Similar changes were seen in metformin (haemoglobin 3-4% and haematocrit 3.6-4.1% relative reductions) and to a lesser extent sulphonylurea and insulin (haemoglobin 1-2% and haematocrit 1-3.2% relative reductions) treated patients in comparative controlled trials with pioglitazone.
Croatian: U usporednim kontroliranim ispitivanjima pioglitazona opažene su slične promjene u bolesnika liječenih metforminom (relativno smanjenje hemoglobina za 3-4% i hematokrita za 3,6-4,1%) i u manjoj mjeri u bolesnika liječenih sulfonilurejom i inzulinom (relativno smanjenje hemoglobina za 1-2% i hematokrita za 1-3,2%).
English: Each tablet contains 92.87 mg of lactose monohydrate (see section 4.4).
Croatian: Jedna tableta sadrži 92,87 mg laktoza hidrata (vidjeti dio 4.4).
English: 6 In active comparator controlled trials mean weight increase with pioglitazone given as monotherapy was 2-3 kg over one year.
Croatian: U ispitivanjima kontroliranima aktivnim usporednim lijekom, prosječno povećanje tjelesne težine tijekom monoterapije pioglitazonom iznosilo je 2-3 kg tijekom jedne godine.
English: Each tablet contains 76.34 mg of lactose monohydrate (see section 4.4).
Croatian: Jedna tableta sadrži 76,34 mg laktoza hidrata (vidjeti dio 4.4).
English: Bladder cancer has been experienced uncommonly (may affect up to 1 in 100 people) in patients taking Actos.
Croatian: Karcinom mokraćnog mjehura manje je često (može se pojaviti u do 1 na 100 osoba) nastao u bolesnika koji uzimaju Actos.
English: How to store Actos
Croatian: Kako čuvati Actos
English: common common common common common blood creatine phospho-kinase increased common increased lactic dehydro-genase uncommon alanine aminotransferase increased7
Croatian: često često često često često povišena kreatin fosfokinaza u krvi često povišena laktična dehidrogenaza manje često povišena alanin aminotransferaza nepoznato nepoznato nepoznato nepoznato nepoznato
English: Fasting and postprandial glycaemic control is improved in patients with type 2 diabetes mellitus.
Croatian: Poboljšava se kontrola glikemije natašte i nakon obroka u bolesnika sa šećernom bolešću tipa
English: Metabolism and nutrition disorders hypo-glycaemia uncommon very common common appetite increased uncommon
Croatian: Poremećaji metabolizma i prehrane hipoglikemija manje često vrlo često često pojačan apetit manje često
English: There was a small reduction in mean haemoglobin (4% relative reduction) and haematocrit (4.1% relative reduction) during therapy with pioglitazone, consistent with haemodilution.
Croatian: Tijekom terapije pioglitazonom došlo je do malog smanjenja prosječne vrijednosti hemoglobina (relativno smanjenje za 4%) i hematokrita (relativno smanjenje za 4,1%), sukladno hemodiluciji.
English: 4 A pooled analysis was conducted of adverse reactions of bone fractures from randomised, comparator controlled, double blind clinical trials in over 8,100 patients in the pioglitazone-treated groups and 7,400 in the comparator-treated groups of up to 3.5 years duration.
Croatian: Provedena je analiza objedinjenih podataka o prijelomima kostiju kao nuspojavama u randomiziranim, usporednim lijekom kontroliranim, dvostruko slijepim kliničkim ispitivanjima u više od 8100 bolesnika u skupinama liječenima pioglitazonom i 7400 bolesnika u skupinama liječenima usporednim lijekom u trajanju do 3,5 godine.
English: Adverse reaction Frequency of adverse reactions of pioglitazone by treatment regimen
Croatian: Učestalost nuspojava pioglitazona prema režimu liječenja
English: - if you are allergic to pioglitazone or any of the other ingredients of this medicine (listed in section 6).
Croatian: Nemojte uzimati Actos - ako ste alergični na pioglitazon ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.). - ako imate zatajenje srca ili ste prije imali zatajenje srca.
English: Heart failure has been reported with marketing use of pioglitazone, and more frequently when pioglitazone was used in combination with insulin or in patients with a history of cardiac failure (see section 4.4).
Croatian: Zatajenje srca uz primjenu pioglitazona zabilježeno je nakon stavljanja lijeka u promet, i bilo je češće kad se pioglitazon primjenjivao u kombinaciji s inzulinom ili u bolesnika sa zatajenjem srca u anamnezi (vidjeti dio 4.4).
English: Allergic reactions have been reported with frequency not known (cannot be estimated from the available data) in patients taking Actos.
Croatian: Kod bolesnika koji su uzimali Actos prijavljene su alergijske reakcije s nepoznatom učestalosti (ne može se procijeniti iz dostupnih podataka).
English: Carmellose calcium Hyprolose
Croatian: Laktoza hidrat
English: Actos 15 mg tablets Actos 30 mg tablets Actos 45 mg tablets
Croatian: Actos 15 mg tablete Actos 30 mg tablete Actos 45 mg tablete pioglitazon
English: Lilly S.A. Tel: +34 (91) 663 50 00
Croatian: Tel: + 34 (91) 663 50 00
English: Lactose monohydrate Magnesium stearate
Croatian: Magnezijev stearat
English: Co-administration of pioglitazone with gemfibrozil (an inhibitor of cytochrome P450 2C8) is reported to result in a 3-fold increase in AUC of pioglitazone.
Croatian: Zabilježeno je da istodobna primjena pioglitazona s gemfibrozilom (inhibitor citokroma P450 2C8) rezultira trostrukim povećanjem AUC-a pioglitazona.
English: common (may affect up to 1 in 10 people) - respiratory infection - abnormal vision - weight gain - numbness uncommon (may affect up to 1 in 100 people) - inflammation of the sinuses (sinusitis) - difficulty sleeping (insomnia)
Croatian: često (mogu se pojaviti u do 1 na 10 osoba) - infekcija dišnih puteva - poremećen vid - povećanje tjelesne težine - utrnulost manje često (mogu se pojaviti u do 1 na 100 osoba)
English: A higher rate of fractures was observed in women taking pioglitazone (2.6%) versus comparator (1.7%).
Croatian: Viša stopa prijeloma bila je primijećena u žena koje su uzimale pioglitazon (2,6%) nego usporedni lijek (1,7%).
English: - if you retain water (fluid retention) or have heart failure problems, in particular if you are over 75 years old.
Croatian: Upozorenja i mjere opreza Obratite se svom liječniku ili ljekarniku prije nego uzmete Actos (pogledajte također dio 4.) - ako zadržavate vodu (nakupljanje tekućine) ili imate tegobe s zatajivanjem srca, osobito ako ste stariji od 75 godina.
English: Actos 30 mg tablets
Croatian: Actos 30 mg tablete
English: common common uncommon macular oedema not known not known not known not known not known
Croatian: Poremećaji oka poremećaj vida često često manje često makularni edem nepoznato nepoznato nepoznato nepoznato nepoznato
English: Takeda Pharma A/S
Croatian: Nositelj odobrenja za stavljanje lijeka u promet Takeda Pharma A/S
English: Actos 45 mg tablets
Croatian: Actos 45 mg tablete
English: Actos 15 mg tablets
Croatian: Actos 15 mg tablete
English: − Actos 45 mg tablets are white to off-white, round, flat tablets marked ‘45' on one face and
Croatian: Actos 45 mg tablete su bijele do gotovo bijele boje, okrugle, plosnate s oznakom ‘45' na jednoj strani i ‘ACTOS' na drugoj strani.
English: 1 Postmarketing reports of hypersensitivity reactions in patients treated with pioglitazone have been reported.
Croatian: Nakon stavljanja lijeka na tržište, kod bolesnika koji su liječeni pioglitazonom prijavljeni su slučajevi reakcija preosjetljivosti.
English: − Actos 30 mg tablets are white to off-white, round, flat tablets marked ‘30' on one face and
Croatian: Actos 30 mg tablete su bijele do gotovo bijele boje, okrugle, plosnate s oznakom ‘30' na jednoj strani i ‘ACTOS' na drugoj strani.
English: Infections and infestations upper respiratory tract infection common common common common common bronchitis common sinusitis uncommon uncommon uncommon uncommon uncommon
Croatian: Infekcije i infestacije infekcije gornjih dišnih puteva često često često često često bronhitis često sinusitis manje često manje često manje često manje često manje često
English: Read the package leaflet before use.
Croatian: NAČIN I PUT(EVI) PRIMJENE LIJEKA Prije uporabe pročitati uputu o lijeku.
English: Each Actos 30 mg tablet contains 30 mg of pioglitazone (as hydrochloride).
Croatian: Jedna tableta lijeka Actos od 30 mg sadrži 30 mg pioglitazona (u obliku pioglitazonklorida).
English: EU/1/00/150/015 EU/1/00/150/016 EU/1/00/150/017 EU/1/00/150/018 EU/1/00/150/019 EU/1/00/150/020 EU/1/00/150/021 EU/1/00/150/022 EU/1/00/150/023 EU/1/00/150/024 EU/1/00/150/025 EU/1/00/150/026 EU/1/00/150/027 EU/1/00/150/028 EU/1/00/150/029 EU/1/00/150/030
Croatian: EU/1/00/150/001 EU/1/00/150/002 EU/1/00/150/003 EU/1/00/150/004 EU/1/00/150/005 EU/1/00/150/006 EU/1/00/150/007 EU/1/00/150/008 EU/1/00/150/009 EU/1/00/150/010 EU/1/00/150/011 EU/1/00/150/012 EU/1/00/150/013 EU/1/00/150/014 EU/1/00/150/015 EU/1/00/150/016 EU/1/00/150/017 EU/1/00/150/018 EU/1/00/150/019 EU/1/00/150/020 EU/1/00/150/021 EU/1/00/150/022 EU/1/00/150/023 EU/1/00/150/024 EU/1/00/150/025 EU/1/00/150/026 EU/1/00/150/027 EU/1/00/150/028 EU/1/00/150/029 EU/1/00/150/030
English: Respiratory, thoracic and mediastinal disorders dyspnoea common
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja dispneja često
English: Each Actos 45 mg tablet contains 45 mg of pioglitazone (as hydrochloride).
Croatian: Jedna tableta lijeka Actos od 45 mg sadrži 45 mg pioglitazona (u obliku pioglitazonklorida).
English: Each Actos 15 mg tablet contains 15 mg of pioglitazone (as hydrochloride).
Croatian: Jedna tableta lijeka Actos od 15 mg sadrži 15 mg pioglitazona (u obliku pioglitazonklorida).
English: The tablets are white to off-white, round, flat and marked ‘45' on one face and ‘ACTOS' on the other face.
Croatian: Tablete su bijele do gotovo bijele boje, okrugle, plosnate i imaju oznaku ‘45' s jedne strane i ‘ACTOS' s druge strane.
English: Nervous system disorders hypo-aesthesia common common common common common headache common uncommon dizziness common insomnia uncommon uncommon uncommon uncommon uncommon
Croatian: Poremećaji živčanog sustava hipoestezija često često često često često glavobolja često manje često omaglica često nesanica manje često manje često manje često manje često manje često
English: EU/1/00/150/011 14 tablets EU/1/00/150/012 28 tablets EU/1/00/150/022 30 tablets EU/1/00/150/013 50 tablets EU/1/00/150/014 56 tablets EU/1/00/150/023 84 tablets EU/1/00/150/024 90 tablets EU/1/00/150/015 98 tablets EU/1/00/150/029 112 tablets EU/1/00/150/030 196 tablets
Croatian: EU/1/00/150/011 14 tableta EU/1/00/150/012 28 tableta EU/1/00/150/022 30 tableta EU/1/00/150/013 50 tableta EU/1/00/150/014 56 tableta EU/1/00/150/023 84 tableta EU/1/00/150/024 90 tableta EU/1/00/150/015 98 tableta EU/1/00/150/029 112 tableta EU/1/00/150/030 196 tableta
English: The tablets are white to off-white, round, flat and marked ‘30' on one face and ‘ACTOS' on the other face.
Croatian: Tablete su bijele do gotovo bijele boje, okrugle, plosnate i imaju oznaku ‘30' s jedne strane i ‘ACTOS' s druge strane.
English: The tablets are white to off-white, round, convex and marked ‘15' on one face and ‘ACTOS' on the other face.
Croatian: Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘15' s jedne strane i ‘ACTOS' s druge strane.
English: Actos 30 mg tablets pioglitazone
Croatian: NAZIV LIJEKA Actos 30 mg tablete pioglitazon
English: EU/1/00/150/008 14 tablets EU/1/00/150/004 28 tablets EU/1/00/150/019 30 tablets EU/1/00/150/005 50 tablets EU/1/00/150/010 56 tablets EU/1/00/150/020 84 tablets EU/1/00/150/021 90 tablets EU/1/00/150/006 98 tablets EU/1/00/150/027 112 tablets EU/1/00/150/028 196 tablets
Croatian: EU/1/00/150/008 14 tableta EU/1/00/150/004 28 tableta EU/1/00/150/019 30 tableta EU/1/00/150/005 50 tableta EU/1/00/150/010 56 tableta EU/1/00/150/020 84 tableta EU/1/00/150/021 90 tableta EU/1/00/150/006 98 tableta EU/1/00/150/027 112 tableta EU/1/00/150/028 196 tableta
English: EU/1/00/150/007 14 tablets EU/1/00/150/001 28 tablets EU/1/00/150/016 30 tablets EU/1/00/150/002 50 tablets EU/1/00/150/009 56 tablets EU/1/00/150/017 84 tablets EU/1/00/150/018 90 tablets EU/1/00/150/003 98 tablets EU/1/00/150/025 112 tablets EU/1/00/150/026 196 tablets
Croatian: EU/1/00/150/007 14 tableta EU/1/00/150/001 28 tableta EU/1/00/150/016 30 tableta EU/1/00/150/002 50 tableta EU/1/00/150/009 56 tableta EU/1/00/150/017 84 tableta EU/1/00/150/018 90 tableta EU/1/00/150/003 98 tableta EU/1/00/150/025 112 tableta EU/1/00/150/026 196 tableta